Cinqair® (reslizumab)
for Asthma

Cinqair (reslizumab) is a monoclonal antibody used with other medications to help control severe asthma in adults. It reduces airway inflammation by lowering certain white blood cell levels, improving breathing over time. Cinqair is for long-term asthma management and does not treat sudden asthma attacks.

Heart
Medication Guide Icon Medication Guide
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Asthma